^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    ADG138

    i
    Other names: ADG138
    Associations
    News
    Trials
    Company:
    Adagene
    Drug class:
    HER2 inhibitor, CD3 agonist, T-cell stimulant
    Related drugs:
    Associations
    News
    Trials